Bill Sponsor
House Bill 2679
118th Congress(2023-2024)
Pharmacy Benefits Manager Accountability Act
Introduced
Introduced
Introduced in House on Apr 18, 2023
Overview
Text
Introduced
Apr 18, 2023
Latest Action
Apr 18, 2023
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2679
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New Hampshire
Democrat
California
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Pharmacy Benefits Manager Accountability Act

This bill establishes reporting requirements for pharmacy benefit managers (PBMs) with respect to services provided to health insurance plans.

First, PBMs must report annually to the plan sponsor certain information about the PBM's services, including the amount of prescription drug copayment assistance funded by drug manufacturers, a list of covered drugs billed under the plan during the reporting period, and the total gross and net spending by the health plan on prescription drugs during the reporting period. PBMs also must submit specified elements of the report (e.g., the total gross spending on prescription drugs) to the Government Accountability Office (GAO). The report must comply with the privacy requirements under the Health Insurance Portability and Accountability Act of 1996.

The bill establishes civil penalties for violations of these requirements and provides for enforcement by the appropriate agencies.

GAO must report on the pharmacy networks of plans or PBMs, including whether such networks under common ownership with the plans or PBMs are designed to encourage plan enrollees to use network pharmacies over other pharmacies.

Text (1)
April 18, 2023
Actions (2)
04/18/2023
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/18/2023
Introduced in House
Public Record
Record Updated
May 21, 2024 2:44:23 PM